CVE-2018-16133
Cybrotech CyBroHttpServer 1.0.3 allows Directory Traversal via a ../ in the URI.
Cybrotech CyBroHttpServer 1.0.3 allows Directory Traversal via a ../ in the URI.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- Low
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
Cybrotech CyBroHttpServer 1.0.3 allows Directory Traversal via a ../ in the URI.
- Record
CVE-2018-16133- CVSS 3.0
- 5.3 Medium
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N - CVSS 2.0
- 5.0 Medium
AV:N/AC:L/Au:N/C:P/I:N/A:N - Weakness
- CWE-22
- Updated
- 2026-11-02
CVE List No score
Cybrotech CyBroHttpServer 1.0.3 allows Directory Traversal via a ../ in the URI.
- Record
CVE-2018-16133- Updated
- 2026-11-02
EUVDEUVD-2018-7988 No score
Cybrotech CyBroHttpServer 1.0.3 allows Directory Traversal via a ../ in the URI.
- Record
EUVD-2018-7988- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-42j3-546g-42hg
Cybrotech CyBroHttpServer 1.0.3 allows Directory Traversal via a ../ in the URI.
Cybrotech CyBroHttpServer 1.0.3 allows Directory Traversal via a ../ in the URI.
- Record
GHSA-42j3-546g-42hg- CVSS 3.0
- 5.3 Medium
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N - Weakness
- CWE-22
- Updated
- 2026-11-02
Affected products
Public exploits
Links only. Every CVE stores no exploit code.
| Source | Link | Date |
|---|---|---|
| Exploit-DB | Cybrotech CyBroHttpServer 1.0.3 - Directory Traversal | 2018-08-30 |
| Nuclei | Cybrotech CyBroHttpServer 1.0.3 - Local File Inclusion |
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, Exploit-DB, GitHub Advisories, Nuclei, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2018-16133 is a medium vulnerability (CVSS 5.3) in Cybrotech Cybrohttpserver, published August 29, 2018. Public exploit code exists. EPSS puts the chance of exploitation in the next 30 days at 38.9%, the 98th percentile. No source names a fixed version.
